1. (a) Cultural environment.
(b) Tiny sector.
(c) Regulatory environment.
(d) Foreign collaboration.
(e) Liberalisation.
(f) Symptoms of sickness.
2. State the changing role of government in business.
3. How do you assess the impact on legal environment on business?
4. Explain the structure of Indian industry.
5. Describe the features of recent industrial policy of India.
6. Critically examine the EXIM policy of India.
7. Enumerate the financial sector reforms introduced in India.
8. Cast study
Nicholas Piramal India, a giant in the pharmaceutical market, achieved a sale growth of 26% in 2003-04 at
about Rs. 1,435 crore, its net profit rose by 60% from Rs. 118 crore in 2002-03 to Rs. 188 crore in 2003-04.
Nicholas Piramal had a different growth strategy as it started as a small player with big dreams. The
strategy was organic growth coupled with acquisitions. Piramal acquired nine entities and integrated them
quickly into the parent company to deliver higher growth from the acquired portfolio.
Nicholas Piramal is also focusing on exports market. It has decided to partner with innovator companies in
global markets, rather than compete or patent litigate against them. Building on this base, the company has
built an export model that delivers the ‘India advantage’ to the global firms. It plans to provide end-to-end
outsourcing solutions across the pharmaceutical life cycle, from custom-made synthesis and bulk
intermediates to formulations. it has established four process development groups at multiple locations in
India and has also set up a 100% subsidiary in the US for closer customer reach. Nicholas Piramal believes
that the future growth driver will be exports, ably supported by a strong domestic market.
Questions :
(a) What are the growth strategies formulated by Nicholas Piramal to explore the opportunities?
(b) What are the risk factors that the company may face in international market?

No comments:

Post a Comment